Stay updated on OCTAPLEX Study in DOAC-Related Major Bleeding Clinical Trial
Sign up to get notified when there's something new on the OCTAPLEX Study in DOAC-Related Major Bleeding Clinical Trial page.

Latest updates to the OCTAPLEX Study in DOAC-Related Major Bleeding Clinical Trial page
- CheckyesterdayChange DetectedThe record history shows Revision: v3.7.0 replacing Revision: v3.6.6, indicating a software revision reflected in the study history page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study record history now shows the latest revision as v3.6.6, replacing the previous v3.6.5 in the version history.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page history now reflects a new site revision label (v3.6.5). The previous revision (v3.6.4) has been removed.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision label on the page was updated from v3.6.3 to v3.6.4. This indicates an incremental update to the page version history rather than a change to study data or content.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision label on the Record History page updated to v3.6.3, indicating a new build/version of the page.SummaryDifference0.1%

- Check87 days agoChange DetectedThe record now shows the study was terminated in February 2026 after an interim analysis, with enrollment suspended since December 22, 2025, and no longer recruiting participants; key sections including Contacts/Locations, Study Design, Study Status, and Recruitment Status were updated, with a final analysis planned for Q2 2026.SummaryDifference0.7%

Stay in the know with updates to OCTAPLEX Study in DOAC-Related Major Bleeding Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OCTAPLEX Study in DOAC-Related Major Bleeding Clinical Trial page.